Navigation Links
BioSpecifics Technologies Corp. Announces Positive Top-line Data from Phase 2 Clinical Trial of CCH for the Treatment of Human Lipoma
Date:1/8/2014

CH in marketed indications, ranging from 0.058mg (10% of commercial dose) to 0.44mg (75% of commercial dose). The primary efficacy outcome was reduction in lipoma visible surface area as measured by caliper. Data showed patients in the highest dose group (75% of commercial dose) achieved the best efficacy results with an average of 67% reduction of lipoma visible surface area as measured by caliper at six months post-treatment. Additionally, data demonstrated that 75% of patients in the highest dose group achieved reduction of 50% or more in lipoma visible surface area.

There were no drug-related serious adverse events reported during the trial. The most frequent treatment-related adverse events were localized to the injection site and included bruising, injection site swelling and injection site pain. These adverse events are consistent with those seen previously in clinical experience.

"We are pleased with the results of this Phase 2 study and believe they indicate strong potential for CCH in human lipomas," said Dr. Zachary Gerut, M.D., Director of the Aesthetic Surgery Center in Hewlett, New York and Lead Investigator of the study. "A non-surgical therapy would be particularly relevant to patients with multiple lipomas. These patients require surgery with multiple excisions, each of which can have complications such as hematoma necessitating further surgery."

BioSpecifics' strategic partner Auxilium Pharmaceuticals, Inc. (Auxilium) has the option to exclusively license development and marketing rights to the human lipoma indication following completion of a new trial, which would trigger an opt-in payment and potential future milestone and royalty payments from Auxilium.

About BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for twelve clinical indications to date. Injectable collagenase i
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
2. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2012 Financial Results on August 9, 2012
3. BioSpecifics Technologies Corp. To Present at Stifel Nicolaus Weisel Healthcare Conference 2012
4. BioSpecifics Technologies Corp. to Present at Two Upcoming Investor Conferences in September
5. BioSpecifics Technologies Corp. to Host Conference Call to Report Third Quarter 2012 Financial Results on November 8, 2012
6. BioSpecifics Technologies Corp. to Webcast, Live, at RetailInvestorConferences.com on December 6th
7. BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences
8. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, March 12, 2013
9. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
10. BioSpecifics Technologies Corp. to Host Conference Call to Report First Quarter 2013 Financial Results on Friday, May 10, 2013
11. BioSpecifics Technologies Corp. to Present at Jefferies 2013 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... und TÜBINGEN, Deutschland, 5. März ... Gates Stiftung und das deutsche biopharmazeutische Unternehmen ... 46 Millionen Euro (52 Millionen US-Dollar) in ... Bereich der medizinisch angewandten Messenger-RNA (mRNA). Auf ... Ansätze zur Behandlung von Krankheiten und zum ...
(Date:3/5/2015)... TÜBINGEN, Germany , March 5, ... Foundation and CureVac today announced that the foundation ... (€46 million) in CureVac, a leading clinical-stage biopharmaceutical ... of the agreement, the foundation will also provide ... vaccines based on CureVac,s proprietary messenger RNA (mRNA) ...
(Date:3/5/2015)...  As the pharmaceutical industry works to address ... professionals are placing a significant emphasis on company ... by LRN, the leader in Ethics & Compliance ... respondents expressed that clarity on company values is ... training programs (57%), trumping understanding of the PhRMA ...
Breaking Medicine Technology:Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 2Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 3Bill & Melinda Gates Stiftung investiert in CureVac zur Entwicklung innovativer Impfstoffe 4The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 2The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 3The Bill & Melinda Gates Foundation and CureVac Collaborate to Accelerate the Development of Transformative Vaccine Technology 4Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 2Pharmaceutical Ethics & Compliance Professionals Place Company Values Front and Center 3
... Mass., Aug. 23, 2011 PrimeraDx today announced the ... instrument on the market used for simultaneous detection and ... SNPs and DNA “We are excited to ... PCR platform,” stated President and CEO Matthew McManus, MD, ...
... 2011 NeoStem, Inc. (NYSE Amex: NBS ... with a focus on cell-based therapeutic development, announced today ... independent registered public accounting firm for fiscal year 2011. ... decision to appoint Grant Thornton LLP as its independent ...
Cached Medicine Technology:PrimeraDx Launches the Only System Capable of Simultaneous Quantification of mRNA, microRNA and DNA 2NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm 2NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm 3
(Date:3/5/2015)... 05, 2015 The Journal of ... a special issue devoted entirely to ... PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococci) ... reaction triggered by infections such as strep throat, ... inflammation of the child's brain. This inflammation causes ...
(Date:3/5/2015)... 2015 Kevin Batsford lost his brother ... of drug addiction. The siblings frequented bridges, highways, and ... to seek refuge during the night. Batsford said that ... for his outward appearance, hygiene, or overall well being- ... Central reported on Feb. 23rd that Batsford left ...
(Date:3/5/2015)... (PRWEB) March 05, 2015 Altec Products, ... solutions, announced today their participation in the Houston, TX ... 2015. The Inspire Tour will unite Sage enterprise resource ... ideas about workable solutions to real-world business challenges. ... the Crowne Plaza Houston Galleria Area on March 10th. ...
(Date:3/5/2015)... Colorful packaging and marketing promises make it ... health. But all it really takes is reading the ... the March 2015 Harvard Health Letter . , ... director of the Department of Nutrition at Harvard-affiliated Brigham ... all the markers of good nutrition. , Whole grains ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
Breaking Medicine News(10 mins):Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 2Health News:Controversial Childhood Illness PANDAS the Focus of a Special Medical Journal Issue 3Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 2Health News:The Homeless’ Unaddressed Drug Addiction Continues to Spiral Out of Control, Harbor Village Detox Stresses Treatment for the Homeless 3Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 2Health News:Altec Attends Sage Inspire Tour Stops in Houston and Charlotte to Showcase Sage ERP Document Management and Workflow Solution 3Health News:Tips to Find the Healthiest Breakfast Cereals, From the March 2015 Harvard Health Letter 2Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2
... Torrance Orthopaedics and Sports Medicine Group Dr. Nicholas ... of Affordable Medical Imaging Systems., REDONDO BEACH, ... of medical imaging systems to healthcare providers,today announced ... their,distinguished board of directors., Dr. Halikis joins ...
... in response to evidence-based recommendations ... drug labels, PHILADELPHIA, Nov. 28 You have just ... label says: "take one,tablet by mouth twice daily for 7 ... This might be easy for you to answer, but 46 ...
... genX International, Inc and,IVFonline, LLC (genX ... products are being sold to some IVF ... distributed by genX International,and IVFonline. Therefore, genX ... Coda(R) products and genX International cannot,guarantee that ...
... researchers at the University of Illinois have uncovered a host ... age, ranging from better brain function to improved immune responses. ... yet another benefit: a link between moderate exercise and decreased ... the study is that moderate exercise sped up how fast ...
... Researchers at the National Institute of Aging and Stanford University ... with age in 16 different mouse tissues. The study, ... database called AGEMAP to document the process of aging in ... aging affects different tissues in mice, and ultimately could help ...
... they could protect against type 2 diabetes , WEDNESDAY, ... treating diseases such as type 2 diabetes show promise, ... a gene controlling the aging process, the researchers report ... , In obese mice, these compounds improved insulin sensitivity, ...
Cached Medicine News:Health News:Prominent Orthopaedic Hand and Upper Extremity Surgeon Joins Radlink Board of Directors 2Health News:System of Simplified, Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communication Conference 2Health News:System of Simplified, Standardized Dosing Instructions for Prescription Medication Container Labels Proposed at Sixth Annual National Health Communication Conference 3Health News:Warning - Beware of Counterfeit Coda(R) Products 2Health News:Exercise may play role in reducing inflammation in damaged skin tissue 2Health News:Exercise may play role in reducing inflammation in damaged skin tissue 3Health News:Exercise may play role in reducing inflammation in damaged skin tissue 4Health News:A molecular map for aging in mice 2
Luria bertani broth: 1.0% Tryptone, 0.5% Yeast Extract, 1.0% Sodium Chloride....
2.5% Soytone, 4.8% Yeast Extract, 0.025% Magnesium Sulfate, 130mM Calcium Chloride....
... Off-white free flowing powder. pH: pH(4.7%, ... Casein Peptone: 24% Yeast Extract: 47% Potassium Phosphate ... To Use: Dissolve 47 gm powder per liter ... of plasmid DNA and recombinant proteins than LB ...
...
Medicine Products: